This SEC filing details transactions by Umesh Padval, a director at Impinj Inc. On May 28, 2026, Mr. Padval acquired 3,114 shares of Common Stock through the vesting of Restricted Stock Units (RSUs). These RSUs were granted on June 5, 2025, and fully vested on May 28, 2026. The filing also reports the acquisition of 1,...

This Form 4 filing reports that Stelios Papadopoulos, a director of Exelixis, Inc., received 8,367 restricted stock units (RSUs) on May 27, 2026. The RSUs were granted under the company's 2017 Equity Incentive Plan and represent the economic equivalent of common stock. The award will vest in full on May 27, 2027, conti...

Andrew T. Swetman, First Vice President and 10% owner of Peoples Financial Corp (PFBX), filed a Form 4 disclosing the sale of 2,000 shares of the company's stock on May 29, 2026. The transaction was executed at a price of $21.25 per share, resulting in total proceeds of $42,500. Following this sale, Swetman's remaining...

George J. Sliman III, a director at Peoples Financial Corp/MS/, reported a transaction on May 29, 2026. Sliman acquired 2,000 shares of the company's stock at a price of $21.25 per share. Following this transaction, Sliman directly owns 5,000 shares of Peoples Financial Corp/MS/. The transaction code used was 'P', indi...

This filing details a transaction by Robert M. Pons, a director at Nano Dimension Ltd. On January 1, 2026, Mr. Pons acquired 260,000 ordinary shares with a transaction price of $0.00. This acquisition consists of 200,000 Restricted Stock Units (RSUs) that vested on January 1, 2026, as approved at the Annual General Mee...

This filing details a transaction by Christine A. Poon, a director at NEUROCRINE BIOSCIENCES INC (NBIX). On May 27, 2026, Ms. Poon acquired 2,567 Restricted Stock Units (RSUs) with a post-transaction share count of 2,567. The RSUs, representing the right to receive one share of common stock upon vesting, will fully ves...

This filing details a transaction by Richard F. Pops, a director at NEUROCRINE BIOSCIENCES INC (NBIX). On May 27, 2026, Pops acquired 2,567 Restricted Stock Units (RSUs) through a direct ownership transaction. The RSUs, representing the right to receive one share of common stock upon vesting, have a transaction price o...

This filing details a grant of 8,367 restricted stock units (RSUs) to George Poste, a director at Exelixis, Inc., on May 27, 2026, under the company's 2017 Equity Incentive Plan. These RSUs are economically equivalent to common stock and will vest fully on May 27, 2027, provided Poste remains in continuous service. The...

Margaret M. Preston, a director at Otis Worldwide Corp, acquired 4,596.74 Deferred Stock Units (DSUs) on May 27, 2026, under the Board of Directors Deferred Stock Unit Plan. These DSUs were granted for her services as a non-employee director and are convertible into an equal number of common stock shares upon retiremen...

Brian J.G. Pereira, a director at PROKIDNEY CORP., acquired 135,000 stock options on May 28, 2026. These options, granted under the company's non-employee director compensation policy, allow the purchase of Class A Common Stock at a price of $1.81 per share. The options are exercisable and will vest in full on the earl...

Uma Sinha, a director at PROKIDNEY CORP., was granted 135,000 stock options on May 28, 2026. These options, exercisable at $1.81 per share, are for the company's Class A Common Stock and will vest in full on the earlier of the one-year anniversary of the grant date or the company's next annual general shareholder meeti...

This filing details a transaction involving Edward Pershing, CEO of PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT), who acquired an 8% Unsecured Convertible Promissory Note with a principal value of $15,000. The note is convertible into Series D-1 Convertible Preferred Stock at a price of $2.862 per share. The Series D-1 Pr...

On May 14, 2026, Vasant Padmanabhan, a director at 3D SYSTEMS CORP (DDD), acquired 45,731 shares of Common Stock. The acquisition was made under the Issuer's 2015 Incentive Plan pursuant to the Non-Employee Director Compensation Policy. The shares were awarded with a transaction price of $0.0. Following this transactio...

Yiannis Pafilis, EVP, Pres., EU, Africa, Asia at Brown-Forman Corp, reported transactions on May 27, 2026. These involved Class A Common stock, with 272 shares acquired at $0.00 and 95 shares disposed of to cover withholding obligations related to performance-based restricted stock units awarded on April 25, 2024. The ...

This Form 4 filing reports that Pan Qing, Chief Financial Officer of Noah Holdings Ltd, received 1,035 ordinary shares on May 29, 2026, through the monthly vesting of restricted stock units (RSUs). The transaction involved the conversion of 103 RSUs (each representing 10 ordinary shares) that vested as part of a schedu...

This filing details several transactions by Samuel Joseph Parisi, VP of Finance (Interim PAO) of Alkermes plc. On May 29, 2026, Mr. Parisi acquired 3,392 ordinary shares at $20.03 per share and an additional 12,825 ordinary shares at $19.34 per share. Concurrently, he disposed of 16,217 ordinary shares. The shares were...

This filing details a transaction by Alla Patlis, Interim Chief Financial Officer & Controller of BRAINSTORM CELL THERAPEUTICS INC. On February 26, 2026, Patlis acquired 100,000 shares of Common Stock via restricted stock units (RSUs) awarded under the company's plan. These RSUs vest in two tranches: 50% upon grant and...

This filing details transactions made by Michael Patsalos-Fox, a director at COGNIZANT TECHNOLOGY SOLUTIONS CORP (CTSH), on May 27, 2026. The transactions include the acquisition of 36.0748 deferred restricted stock units and 18.0122 restricted stock units. These units are related to dividend equivalents on previously ...

Robert Strobo, Chief Legal Officer of Paysign, Inc., reported two transactions on May 27, 2026. First, 66,667 shares of common stock were acquired as a result of performance-based restricted stock vesting, as per footnote F1. This acquisition was part of a plan tied to achieving specific earnings targets. Second, 39,23...

Jane Pearce, Managing Director of Trust at Bank of N.T. Butterfield & Son Ltd, acquired 50 restricted stock units under the EDIP plan and 342 restricted stock units under the ELTIP plan on May 27, 2026. Each restricted stock unit represents a contingent right to receive one ordinary share upon vesting. The EDIP units v...

Nancy D. Pellegrino, a director at Mechanics Bancorp, reported a transaction on May 28, 2026. She was granted 5,513 Restricted Stock Units (RSUs), which represent a contingent right to receive one share of Class A common stock upon vesting. These RSUs vest on May 28, 2027, and do not require any payment from the holder...

Brian J.G. Pereira, a director at PROKIDNEY CORP., acquired 135,000 stock options on May 28, 2026. These options, granted under the company's non-employee director compensation policy, allow the purchase of Class A Common Stock at a price of $1.81 per share. The options are exercisable and will vest in full on the earl...

This filing details transactions by reporting owner Perez-Tenessa Alejandro, a director at Employers Holdings, Inc. On May 27, 2026, 55 Dividend Equivalent Rights (DERs) were acquired, economically equivalent to 55 shares of common stock. These DERs are linked to previously granted restricted stock units (RSUs) that ve...

This filing details a transaction involving Edward Pershing, CEO of PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT), who acquired an 8% Unsecured Convertible Promissory Note with a principal value of $15,000. The note is convertible into Series D-1 Convertible Preferred Stock at a price of $2.862 per share. The Series D-1 Pr...

On May 29, 2026, Personalis, Inc. CFO and COO Aaron Tachibana executed a series of transactions under a Rule 10b5-1 trading plan adopted on August 7, 2025. Tachibana exercised 38,799 stock options at an exercise price of $9.16 per share, acquiring the underlying common stock. He then sold the same 38,799 shares at a we...